Cargando…

Six-Transmembrane Epithelial Antigen of Prostate 3 Promotes Hepatic Insulin Resistance and Steatosis

Nonalcoholic fatty liver disease (NAFLD) is a clinicopathological syndrome characterized by excessive deposition of fatty acids in the liver. Further deterioration leads to nonalcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma, creating a heavy burden on human health and the social e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Ting, Chen, Siping, Xiao, Wenchang, Liu, Zhen, Tu, Jun, Yu, Yongjie, Dong, Bizhen, Chen, Wenping, Zeng, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823233/ https://www.ncbi.nlm.nih.gov/pubmed/36495944 http://dx.doi.org/10.1016/j.jlr.2022.100318

Ejemplares similares

Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2
por: Chen, Kehan, et al.
Publicado: (2023)

Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer
por: Fang, Ze-Xuan, et al.
Publicado: (2022)

Regulatory Roles of Six-Transmembrane Epithelial Antigen of the Prostate Family Members in the Occurrence and Development of Malignant Tumors
por: Chen, Wen-Jia, et al.
Publicado: (2021)

Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma
por: Ju, Mi Ha, et al.
Publicado: (2023)

Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion
por: Han, Mingzhi, et al.
Publicado: (2018)

STEAP1–4 (Six-Transmembrane Epithelial Antigen of the Prostate 1–4) and Their Clinical Implications for Prostate Cancer
por: Xu, Michael, et al.
Publicado: (2022)

High expression of six-transmembrane epithelial antigen of prostate 3 promotes the migration and invasion and predicts unfavorable prognosis in glioma
por: Deng, Langmei, et al.
Publicado: (2023)

Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
por: Hayashi, Satoshi, et al.
Publicado: (2011)

Specific Six-Transmembrane Epithelial Antigen of the Prostate 1 Capture with Gellan Gum Microspheres: Design, Optimization and Integration
por: Batista-Silva, João, et al.
Publicado: (2023)

Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer
por: Fang, Ze-Xuan, et al.
Publicado: (2023)

Six-transmembrane epithelial antigen of the prostate 1 accelerates cell proliferation by targeting c-Myc in liver cancer cells
por: Iijima, Kazutaka, et al.
Publicado: (2021)

Cryo-electron microscopy structure and potential enzymatic function of human six-transmembrane epithelial antigen of the prostate 1 (STEAP1)
por: Oosterheert, Wout, et al.
Publicado: (2020)

Murine double minute 2 aggravates adipose tissue dysfunction through ubiquitin-mediated six-transmembrane epithelial antigen of prostate 4 degradation
por: Zhao, Wei, et al.
Publicado: (2022)

Insulin resistance, steatosis and hepatitis C virus
por: Mangia, Alessandra, et al.
Publicado: (2013)

Hepatitis C Virus, Insulin Resistance, and Steatosis
por: Kralj, Dominik, et al.
Publicado: (2016)

Six‐Transmembrane Epithelial Antigen of the Prostate 3 Deficiency in Hepatocytes Protects the Liver Against Ischemia‐Reperfusion Injury by Suppressing Transforming Growth Factor‐β‐Activated Kinase 1
por: Guo, Wen‐Zhi, et al.
Publicado: (2019)

Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance
por: Qiao, Lu, et al.
Publicado: (2022)

Six‐transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial–mesenchymal
por: Wei, Haotian, et al.
Publicado: (2023)

Molecular mechanisms involved in hepatic steatosis and insulin resistance
por: Matsuzaka, Takashi, et al.
Publicado: (2011)

Targeting peroxisomal fatty acid oxidation improves hepatic steatosis and insulin resistance in obese mice
por: Yao, Haoya, et al.
Publicado: (2022)

Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis
por: Elfaal, Mohamed, et al.
Publicado: (2023)

Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance
por: Chen, Weiyu, et al.
Publicado: (2021)

Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
por: Chang, Ting-Chen, et al.
Publicado: (2019)

Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
por: Visser, M. E., et al.
Publicado: (2011)

Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
por: Kern, Matthias, et al.
Publicado: (2012)

Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance
por: Kahl, Sabine, et al.
Publicado: (2014)

Reducing endogenous insulin is linked with protection against hepatic steatosis in mice
por: Akheruzzaman, Md, et al.
Publicado: (2020)

Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hepatic steatosis
por: Li, Ying, et al.
Publicado: (2022)

Blocking Nuclear Factor-Kappa B Protects against Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice
por: Zeng, Tianshu, et al.
Publicado: (2016)

Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight/obese Chinese adults
por: Ma, Danyan, et al.
Publicado: (2021)

Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice
por: Choi, Bong-Hoi, et al.
Publicado: (2018)

Regulatory Role of Endothelial PHD2 in the Hepatic Steatosis
por: Zhou, Li-Ying, et al.
Publicado: (2018)

Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance
por: Lee, Hui-Young, et al.
Publicado: (2011)

Hepatic Subcapsular Steatosis in a Diabetic CAPD Patient Receiving Intraperitoneal Insulin
por: Jang, Eun Chul, et al.
Publicado: (2006)

Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver
por: Zhang, Yuehui, et al.
Publicado: (2018)

Human hepatic 3D spheroids as a model for steatosis and insulin resistance
por: Kozyra, Mikael, et al.
Publicado: (2018)

Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control
por: Ciresi, Alessandro, et al.
Publicado: (2018)

Case Report: High-concentration Insulin Glargine Overdose Complicated by Hepatic Steatosis
por: Endall, Ryan, et al.
Publicado: (2020)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_274a88kuqdm31096k7evh2tsvl